Padcev, an antibody-drug conjugate which Pfizer acquired via its $43 billion Seagen deal, could help people who don’t qualify ...

Biotechs are coming to the island as tariffs threaten overseas drug exports, and finding Puerto Rico is more than just a ...

Arcus Biosciences nears key catalysts with late-stage assets & upcoming Phase 3 data. Discover potential upside & why it's ...

Patients with psoriasis have significantly more difficulty sleeping, particularly in new environments, than matched ...

Type II cryoglobulinemic vasculitis in patients with Sjögren disease is associated with nearly a sevenfold increased risk for ...

Ford Is Taking on Expensive EVs and the Toyota RAV4 with Its New 'Model T'—a $30K Mid-Size EV Truck ‘What gives you the right ...

The objective response rate (ORR) was 32% with adagrasib versus 9% with docetaxel (OR 4.68, 95% CI 2.56-8.56, P <0.0001), ...

Known for producing companies like Karuna Therapeutics, which was sold to Bristol Myers Squibb for $14 billion, and newly ...

Even though Bristol-Myers Squibb Company's ( NYSE:BMY ) recent earnings release was robust, the market didn't seem ...

When a mental health crisis unfolds in Miami-Dade County, a call to 1-866-SAFEMIA brings a different kind of first responder.

Editas Medicine's shares are up in 2025, but the stock has lagged the market in recent years. The struggling biotech decided ...

Bristol-Myers Squibb Company (NYSE: BMY) is one of the stocks Jim Cramer recently shed light on. When a caller noted that the ...